Delving into the Latest Updates on Lyophilized BPI viper antivenom(University of Oxford) with Synapse

Overview

Basic Info

Drug Type

Antitoxin

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Hemic and Lymphatic DiseasesOther Diseases

Active Indication-

Inactive Indication

Blood Coagulation DisordersSnake Bites

Originator Organization

University of Oxford

Active Organization-

Inactive Organization

University of Oxford

Drug Highest PhaseSuspendedPhase 2

First Approval Date-

Regulation-

Login to view timeline

The aim of the study is to identify an 'optimal' initial dosing of the new Burma Pharmaceutical Industry (BPI) lyophilized mono-specific antivenom for patients with systemic Daboia siamensis envenoming. The initial dosing will aim to reverse venom-induced coagulopathy (as demonstrated by a negative 20 minutes Whole Blood Clotting Time (20WBCT) at 6 hours in 95% of patients whilst causing less than 5% anaphylactic reaction.

Start Date01 Apr 2025

Sponsor / Collaborator

University of Oxford

100 Clinical Results associated with Lyophilized BPI viper antivenom(University of Oxford)

Login to view more data

100 Translational Medicine associated with Lyophilized BPI viper antivenom(University of Oxford)

Login to view more data

100 Patents (Medical) associated with Lyophilized BPI viper antivenom(University of Oxford)

Login to view more data

100 Deals associated with Lyophilized BPI viper antivenom(University of Oxford)

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Blood Coagulation Disorders	Phase 2	Myanmar (Burma)	University of Oxford	-
Snake Bites	Phase 2	Myanmar (Burma)	University of Oxford	-

Login to view more data

Clinical Result

Indication

Phase

Evaluation

View All Results

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.

login

or

view full example data

Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.

login

or

view full example data

Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.

login

or

view full example data

Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.

login

or

view full example data

Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.

login

or

view full example data

Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

login

or

view full example data